Joshua Levy

Project Scientist

Scripps Research Institute
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (8)

Year:

2026

Measles outbreaks have surged globally in recent years, but current surveillance systems have limited capacity to monitor measles virus (MeV) transmission and evolution at population scale. Although MeV can be detected in wastewater, the public health potential of wastewater genomic surveillance for MeV remains largely unexplored. Here, we deploy sensitive, low-cost MeV wastewater genomic surveillance combining virus concentration, whole-genome amplicon sequencing, and bioinformatic analysis alongside routine clinical genomic surveillance during the 2024-25 outbreak in South Africa. Integrated phylogenetic analyses of wastewater and clinical MeV genomes revealed previously undetected interprovincial spread and transmission links not captured by standard N450 sequencing. Our findings demonstrate that wastewater-integrated whole-genome surveillance expands the coverage and resolution of routine MeV monitoring and provides a scalable tool to advance measles control and elimination efforts.

Year:

2026

Timely pathogen surveillance and reporting is essential for effective public health guidance. Web dashboards have become a key tool for communicating public health information to stakeholders, health care workers, and the broader community. Over the SARS-CoV-2 pandemic, wastewater surveillance has increasingly been incorporated into public health workflows for outbreak monitoring and response, enabling community-representative and low-cost monitoring to supplement clinical surveillance. However, the methods used for visualization and dissemination of clinical and wastewater surveillance data differ across programs, and best practices are yet to be defined. In this work, we demonstrate data workflows and dashboards used to perform wastewater-based public health surveillance in tandem with clinical data across local and national scales, leveraging custom-built, reproducible, and open-source software. Using a centralized data aggregation and analysis hub approach, we establish multiple data pipelines for data storage, wrangling, and standardized analyses, and deploy custom-built web dashboards that allow for immediate public release. We find that our approach is effective across scales, computing architectures, and dissemination strategies, and provides an adaptable model to incorporate additional pathogens and epidemiological data.

Year:

2025

In January 2025, Sierra Leone reported its first mpox case in eight years, followed by a rapid nationwide surge that made it the epicenter of the continental mpox virus (MPXV) Clade IIb A.2.2 outbreak, with more than 5,000 confirmed cases reported by August. To investigate the origin, timing, and spread of this epidemic, we generated 338 high-quality MPXV genomes from cases across 14 districts and conducted Bayesian phylogeographic analyses. We found that transmission was driven by a newly emerging Clade IIb lineage, G.1, descended from lineages circulating in the ongoing Nigerian epidemic. Phylogeographic reconstructions indicate that G.1 arose in late September 2024 and circulated undetected for approximately three months before establishing sustained transmission in the densely populated Western Area Urban and Rural districts, which became the principal source of repeated viral introductions that drove epidemics in other regions. Together, these findings reveal the origins and dispersal dynamics of the 2025 mpox outbreak in Sierra Leone and underscore that effective control remains achievable through targeted vaccination, strengthened early warning systems, and improved access to genomic and diagnostic surveillance.

Year:

2025

Case-based infectious disease surveillance is fundamental to public health, but is resource-intensive, logistically complex, and prone to sampling bias. Wastewater testing and sequencing have increasingly been used for population-scale monitoring of pathogen dynamics, including in low-resource settings. Broader adoption of wastewater genomic surveillance, however, is limited by a lack of flexibility across sequencing platforms and approaches, and adaptability to additional pathogens. Here, we describe “Freyja 2”, an integrated bioinformatics tool enabling robust real-time inference of pathogen lineage prevalence and growth dynamics from wastewater and other complex samples. In Freyja 2, we develop new methods for estimating lineage prevalence and growth rates, and demonstrate robustness across common sequencing platforms and to low genomic coverage. By incorporating global pathogen data streams, we extend Freyja 2 to support multi-pathogen surveillance. We demonstrate tracking of multiple recent or ongoing public health emergencies, including COVID-19, mpox, and H5N1 influenza, revealing unreported diversity and lineage co-circulation.

Year:

2025

Timely pathogen surveillance and reporting is essential for effective public health guidance. Web dashboards have become a key tool for communicating public health information to stakeholders, health care workers, and the broader community. Over the SARS-CoV-2 pandemic, wastewater surveillance has increasingly been incorporated into public health workflows for outbreak monitoring and response, enabling community-representative and low-cost monitoring to supplement clinical surveillance. However, the methods used for visualization and dissemination of clinical and wastewater surveillance data differ across programs and best practices are yet to be defined. In this work, we demonstrate data workflows and dashboards used to perform wastewater-based public health surveillance in tandem with clinical data across local and national scales, leveraging custom-built, reproducible, and open-source software. Using a centralized data aggregation and analysis hub approach, we establish multiple data pipelines for data storage, wrangling, and standardized analyses, and deploy custom-built web dashboards that allow for immediate public release. We find that our approach is effective across scales, computing architectures, and dissemination strategies, and provides an adaptable model to incorporate additional pathogens and epidemiological data.

Year:

2025

Year:

2023

Year:

2023

Collaborators (7)

Andrew Rambaut

Professor

University of Edinburgh

UNITED KINGDOM
View details

Daniel Park

Group Leader

Broad Institute

UNITED STATES
View details

Kristian Andersen

Professor

Scripps Research Institute

UNITED STATES
View details

Martin Hölzer

Robert Koch Institute

GERMANY
View details

Nicola J Mulder

University of Cape Town

SOUTH AFRICA
View details

Al Ozonoff

Associate Professor

Harvard University

UNITED STATES
View details

Emily Smith

University of Minnesota Twin Cities

UNITED STATES
View details